ArticleJCO precision oncology2020

Long-Lasting Response to Nivolumab for a Patient With Lynch Syndrome-Associated Lung Adenocarcinoma.

Keita Masuzawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.